###begin article-title 0
###xml 25 30 <span type="species:ncbi:9606">Human</span>
###xml 100 105 <span type="species:ncbi:9606">Women</span>
Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women
###end article-title 0
###begin p 1
Conceived and designed the experiments: TRH DS SL AS AA WES LPPZ TMH. Performed the experiments: TRH MJ. Analyzed the data: TRH DS HW SL AS MJ AA LPPZ TMH. Wrote the paper: TRH DS HW SL AS MJ AA WES LPPZ TMH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:9606">women</span>
Although several studies suggest that genetic factors are associated with human UTI susceptibility, the role of DNA variation in regulating early in vivo urine inflammatory responses has not been fully examined. We examined whether candidate gene polymorphisms were associated with altered urine inflammatory profiles in asymptomatic women with or without bacteriuria.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 96 101 <span type="species:ncbi:9606">women</span>
###xml 142 154 <span type="species:ncbi:9606">participants</span>
###xml 314 319 <span type="species:ncbi:9606">women</span>
We conducted a cross-sectional analysis of asymptomatic bacteriuria (ASB) in 1,261 asymptomatic women ages 18-49 years originally enrolled as participants in a population-based case-control study of recurrent UTI and pyelonephritis. We genotyped polymorphisms in CXCR1, CXCR2, TLR1, TLR2, TLR4, TLR5, and TIRAP in women with and without ASB. We collected urine samples and measured levels of uropathogenic bacteria, neutrophils, and chemokines.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 549 554 <span type="species:ncbi:9606">women</span>
Polymorphism TLR2_G2258A, a variant associated with decreased lipopeptide-induced signaling, was associated with increased ASB risk (odds ratio 3.44, 95%CI; 1.65-7.17). Three CXCR1 polymorphisms were associated with ASB caused by gram-positive organisms. ASB was associated with urinary CXCL-8 levels, but not CXCL-5, CXCL-6, or sICAM-1 (P</=0.0001). Urinary levels of CXCL-8 and CXCL-6, but not ICAM-1, were associated with higher neutrophil levels (P</=0.0001). In addition, polymorphism CXCR1_G827C was associated with increased CXCL-8 levels in women with ASB (P = 0.004).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 197 <span type="species:ncbi:9606">human</span>
TLR2 and CXCR1 polymorphisms were associated with ASB and a CXCR1 variant was associated with urine CXCL-8 levels. These results suggest that genetic factors are associated with early in vivo human bladder immune responses prior to the development of symptomatic UTIs.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 114 117 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Norden1">[1]</xref>
###xml 440 441 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 550 553 548 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kunin1">[2]</xref>
###xml 555 558 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Gaymans1">[3]</xref>
###xml 560 563 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hooton1">[4]</xref>
###xml 721 724 719 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Norden1">[1]</xref>
###xml 726 729 724 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Marple1">[5]</xref>
###xml 731 734 729 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kass1">[6]</xref>
###xml 809 810 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 913 916 909 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kunin1">[2]</xref>
###xml 918 921 914 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Gaymans1">[3]</xref>
###xml 923 926 919 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hooton1">[4]</xref>
###xml 1044 1047 1040 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kunin1">[2]</xref>
###xml 1049 1052 1045 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hooton1">[4]</xref>
###xml 1054 1057 1050 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Bengtsson1">[7]</xref>
###xml 1059 1062 1055 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Nicolle1">[8]</xref>
###xml 1219 1222 1215 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hooton1">[4]</xref>
###xml 1224 1227 1220 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Strom1">[9]</xref>
###xml 544 549 <span type="species:ncbi:9606">women</span>
###xml 1254 1259 <span type="species:ncbi:9606">women</span>
Over 100 years ago, scientists observed that bacteriuria could occur in the absence of urinary tract inflammation [1]. This simple fact suggests that although bacteria are capable of inducing bladder inflammation, their presence alone may not necessarily be sufficient to produce an inflammatory response. Thus, bladder inflammation may be regulated by variation in the host response. Although urine is usually sterile, bacteriuria at >/=105 colony-forming units (cfu)/mL is found in approximately 5-10% of healthy, asymptomatic pre-menopausal women [2], [3], [4]. Quantification of bacteriuria was established over 50 years ago as a means to differentiate true bladder bacteriuria from contamination with perineal flora [1], [5], [6]. Several studies demonstrated that asymptomatic bacteriuria (ASB) at >/=105 cfu/ml is associated with an increased risk of developing a symptomatic urinary tract infection (UTI) [2], [3], [4]. Despite its prevalence, the pathogenesis of ASB and risk factors for progression to acute UTI are poorly understood [2], [4], [7], [8]. Similar to acute UTI, ASB has been associated with behavioral risk factors such as sexual activity and contraceptive choice (diaphragm and spermicide use) [4], [9]. However, the majority of women have no obvious functional or anatomic risk factors predisposing them to ASB, which suggests that genetic factors may modulate the risk of acquiring ASB.
###end p 11
###begin p 12
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Beutler1">[10]</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Svanborg1">[11]</xref>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Akira1">[12]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Beutler2">[13]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Medzhitov1">[14]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Beutler1">[10]</xref>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Svanborg1">[11]</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-AndersenNissen1">[15]</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Shahin1">[16]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Zhang1">[17]</xref>
###xml 281 288 <span type="species:ncbi:562">E. coli</span>
###xml 395 401 <span type="species:ncbi:9606">humans</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
After colonization of the urethra and ascent to the bladder, bacteria bind to glycosphingolipid and glycoprotein receptors on urinary tract epithelium and are detected by the innate immune system through pattern recognition receptors such as Toll-like receptors (TLRs) [10], [11]. E. coli, which causes 70-90% of all uncomplicated UTIs, is recognized by several TLRs, including TLR1,2,4,5,6 (in humans and mice) and 11 (in mice) [12], [13], [14]. TLRs are located on the cell surface or within organelles such as phagosomes, where they detect microbial ligands such as flagellin (TLR5), lipopolysaccharide (LPS) (TLR4), and bacterial lipopeptides (TLR1/2/6) [10]. Although previous studies in mice indicate that TLRs regulate susceptibility to cystitis and pyelonephritis, TLR modulation of human in vivo bladder immune responses is poorly understood [11], [15], [16], [17].
###end p 12
###begin p 13
###xml 149 153 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Beutler1">[10]</xref>
###xml 155 159 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Viola1">[18]</xref>
###xml 267 271 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Benson1">[19]</xref>
###xml 273 277 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Davidoff1">[20]</xref>
###xml 279 283 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hedges1">[21]</xref>
###xml 285 289 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Jacobson1">[22]</xref>
###xml 291 295 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Jantausch1">[23]</xref>
###xml 297 301 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kassir1">[24]</xref>
###xml 303 307 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ko1">[25]</xref>
###xml 309 313 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Olszyna1">[26]</xref>
###xml 315 319 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Otto1">[27]</xref>
###xml 321 325 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Otto2">[28]</xref>
###xml 491 495 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Frendeus1">[29]</xref>
###xml 497 501 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Olszyna2">[30]</xref>
###xml 632 636 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Frendeus1">[29]</xref>
###xml 1035 1039 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Viola1">[18]</xref>
###xml 1272 1276 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Sligh1">[31]</xref>
###xml 503 507 <span type="species:ncbi:10090">Mice</span>
###xml 595 601 <span type="species:ncbi:9606">humans</span>
After activation, TLRs mediate signaling pathways that include activation of NF-kappaB and secretion of chemokines such as CXCL-8 (also called IL-8) [10], [18]. Several clinical studies have demonstrated CXCL-8 in the urine of individuals with acute, symptomatic UTI [19], [20], [21], [22], [23], [24], [25], [26], [27], [28]. Neutrophils migrate from blood vessels to the bladder or kidneys in response to CXCL-8, which binds to the CXCR1 and CXCR2 receptors (also called IL-8RA and IL8RB) [29], [30]. Mice with defects in the IL-8 receptor homologue (mIL-8Rh, homologous to CXCR1 and CXCR2 in humans) are more susceptible to UTIs [29]. After reaching the bladder lumen, neutrophils bind, phagocytose, and eliminate the bacteria. In addition to CXCL-8, several other chemokines are secreted by epithelial cells and induce neutrophil migration including CXCL-5 (also called ENA-78 (Epithelial Cell-Derived Neutrophil-Activating Protein-78)) and CXCL-6 (also called GCP2 (Granulocyte Chemotactic Protein 2)), which also bind to CXCR1/2 [18]. Additional chemotactic molecules operate in blood vessels including sICAM-1 (soluble intercellular adhesion molecule 1), which binds to the CD11b/CD18 (Mac-1) integrin receptor and induces transendothelial migration of neutrophils [31]. Together, these data suggest that several molecules and inflammatory pathways are important in neutrophil migration into the bladder and thus UTI pathogenesis.
###end p 13
###begin p 14
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Casanova1">[32]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Cooke1">[33]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Sorensen1">[34]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hopkins1">[35]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt1">[36]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt2">[37]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt1">[36]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Scholes1">[38]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Scholes2">[39]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt2">[37]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hooton2">[40]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kinane1">[41]</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Sheinfeld1">[42]</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ishitoya1">[43]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lomberg1">[44]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Tomisawa1">[45]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Artifoni1">[46]</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Tabel1">[47]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Karoly1">[48]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Frendeus1">[29]</xref>
###xml 933 937 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt2">[37]</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ragnarsdottir1">[50]</xref>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Smithson1">[51]</xref>
###xml 1107 1111 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 1267 1271 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Tabel1">[47]</xref>
###xml 1353 1357 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ragnarsdottir1">[50]</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 299 307 <span type="species:ncbi:9606">children</span>
###xml 403 408 <span type="species:ncbi:9606">women</span>
###xml 576 582 <span type="species:ncbi:9606">humans</span>
###xml 1101 1106 <span type="species:ncbi:9606">women</span>
###xml 1258 1266 <span type="species:ncbi:9606">children</span>
A series of studies over several decades indicates that host genetic factors influence susceptibility to human infections [32], [33], [34]. More recent studies suggest an influence of genetics on susceptibility to UTIs [35], [36], [37]. In one family study, 15% of relatives of pyelonephritis-prone children had a UTI history compared to 3% of relatives of controls [36]. We previously found that adult women with rUTI or pyelonephritis were more likely to have a mother with a UTI history in comparison to controls [38], [39]. Susceptibility to rUTI and/or pyelonephritis in humans is associated with polymorphisms in the genes for non-secretor blood group antigens, P1 phenotype, CXCR1, TLR1, TLR2, TLR4, and TLR5 [37], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49]. In addition, reduced expression levels of CXCR1 and CXCR2 on neutrophils was associated with pyelonephritis and recurrent cystitis, respectively [29], [37], [50], [51]. We recently found associations of variants of TLRs 1, 4, and 5 with susceptibility to cystitis and/or pyelonephritis in a case-control study of adult women [49]. Studies of genetic variation and ASB have been more limited, with one previous study demonstrating an association of SNP TLR2_G2258A with ASB in children [47]. Reduced expression levels of TLR4 were associated with an increased risk of ASB [50]. To our knowledge, no studies have examined whether polymorphisms are associated with bacteriuria or altered urinary chemokine or neutrophil levels in asymptomatic adults.
###end p 14
###begin p 15
###xml 392 399 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 176 181 <span type="species:ncbi:9606">women</span>
###xml 386 391 <span type="species:ncbi:9606">human</span>
In this study, we examined whether CXCR1, CXCR2, and TLR pathway polymorphisms are associated with ASB, urinary chemokines, and neutrophils in a cross-sectional study of adult women ages 18-49 years with and without a history of recurrent cystitis or pyelonephritis. Asymptomatic bacteriuria provides an opportunity to investigate the role of genetic factors in the early phases of the human in vivo host immune response to bacteria.
###end p 15
###begin title 16
Materials and Methods
###end title 16
###begin title 17
###xml 18 30 <span type="species:ncbi:9606">Participants</span>
Study Setting and Participants
###end title 17
###begin p 18
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 1016 1017 1014 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1394 1395 1390 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
###xml 446 451 <span type="species:ncbi:9606">women</span>
###xml 1133 1138 <span type="species:ncbi:9606">Women</span>
###xml 1513 1518 <span type="species:ncbi:9606">women</span>
###xml 1741 1753 <span type="species:ncbi:9606">participants</span>
The study protocols were approved by the Human Subjects committees at Group Health Cooperative, the University of Washington, and Western Institutional Review Board. The study was conducted at Group Health Cooperative in Seattle, Washington. Written informed consent was obtained from all subjects. We performed a cross-sectional study to examine whether candidate gene polymorphisms are associated with ASB or urine inflammatory markers in 1261 women. The subjects were enrolled as part of a case-control study of rUTI and pyelonephritis that has been previously described [49]. Briefly, we selected potential rUTI and pyelonephritis cases from the health plan's automated databases identified through having received an International Classification of Diseases (ICD-9) diagnosis code. Recurrent cystitis (rUTI) case subjects (n = 431) were identified based on 3 diagnosed UTI episodes within a 12-month time frame or 2 UTIs within 6 months (episodes were separated by at least 30 days). Culture confirmation (>/=103 cfu/mL of a urinary pathogen) or UTI guideline-related treatment was required for all UTI episodes in the cluster. Women experiencing previous pyelonephritis (n = 400) were identified through having received a pyelonephritis ICD-9 diagnosis code and, if they received only outpatient treatment, a primary diagnosis of pyelonephritis and an accompanying culture result of >/=103 cfu/mL of a urinary pathogen or accompanying antibiotic therapy appropriate for pyelonephritis. The remainder of the women constituted the potential control subjects (n = 430) with no history of UTIs who were randomly selected and frequency-matched by case age group (age categories were 18-29, 30-39, 40-49 years). For these analyses, the 1261 participants, all asymptomatic at their study clinic visits, were classified into groups of ASB status based on the urine bacterial counts.
###end p 18
###begin title 19
Urine Specimen Collection and Processing
###end title 19
###begin p 20
###xml 596 600 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Murray1">[52]</xref>
###xml 654 655 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 698 705 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1136 1138 1119 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 698 705 <span type="species:ncbi:562">E. coli</span>
Subjects were asymptomatic at the time of their clinic visits. We collected a clean-catch midstream urine specimen in a sterile BD Vacutainertrade mark Urine Tube (Becton, Dickinson and Company) containing a lyophilized preservative including boric acid and sodium formate. Specimens were stored at room temperature and transported to the laboratory within 72 hours where they were inoculated onto blood agar, MacConkey, and CNA plates. Plates were incubated at 37degreesC for 48 hours, and organisms were quantified in colony-forming units (cfu)/ml and further identified using standard methods [52]. All uropathogens present in midstream urine at >/=103 cfu/ml were identified and quantified and E. coli were characterized as beta- or non-hemolytic. A second urine sample was collected in a sterile container to measure urinary neutrophil levels with a dipstick assay (Bayer Multistix Reagent Strips) and reported on a scale of negative, trace, small (+1), moderate (+2), or large (+3). The trace category was excluded from the analysis. The negative category was compared to the 3 other values. In addition, 2 mls of urine from the 2nd collection were immediately frozen and stored at -70degreesC for later testing for IL-6, CXCL-8, CXCL-5, CXCL-6, and sICAM-1 levels. Prior to testing, specimens were centrifuged at 12,000 RPM for 2 minutes, and the supernatants were removed for analysis. The supernatant was subjected to a sandwich ELISA technique (Duoset, R&D Systems, Minneapolis, MN). Values below the lowest detectable limit of the assay were replaced as zero (lowest detectable values for CXCL-8, CXCL-5, CXCL-6, sICAM-1 were 32.5, 16.1, 6.1, and 6.1 respectively).
###end p 20
###begin title 21
Genomic Techniques
###end title 21
###begin p 22
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Liu1">[53]</xref>
###xml 619 621 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn2">[54]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Storm1">[55]</xref>
Genomic DNA was purified from peripheral blood by QIAamp DNA blood kit (Qiagen). For genotyping in the full cohort, we generated haplotype-tagging SNPs from our sequencing data as well as publicly available data from the Innate Immunity Program in Genomic Applications (IIPGA, ). For determining haplotype tagging SNPs, we selected polymorphisms in the chromosomal region of each gene which represented the commonly inherited haplotypes (combinations of individual alleles). Selection criteria were based on linkage disequilibrium measurements between the polymorphisms [53]. Genotyping was carried out with a MassARRAYTM technique (Sequenom) as previously described [54], [55].
###end p 22
###begin title 23
Statistical Analyses
###end title 23
###begin p 24
###xml 359 360 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 402 403 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 411 412 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 455 456 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1181 1188 1177 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1204 1211 1200 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1228 1235 1221 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteus</italic>
###xml 1245 1257 1238 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacter</italic>
###xml 1267 1277 1260 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebsiella</italic>
###xml 1287 1298 1280 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Citrobacter</italic>
###xml 1312 1331 1305 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Morganella morganii</italic>
###xml 1369 1381 1362 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus</italic>
###xml 1391 1404 1384 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactobacillus</italic>
###xml 1437 1458 1430 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 1464 1480 1457 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. saprophyticus</italic>
###xml 1181 1188 <span type="species:ncbi:562">E. coli</span>
###xml 1204 1211 <span type="species:ncbi:562">E. coli</span>
###xml 1312 1331 <span type="species:ncbi:582">Morganella morganii</span>
###xml 1437 1458 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1464 1480 <span type="species:ncbi:29385|species:ncbi:285455">S. saprophyticus</span>
Several different exposures and outcomes were assessed in the analysis. For the primary analysis, polymorphisms of candidate genes were classified as exposures and ASB or urine inflammatory markers (chemokines or neutrophils) were treated as the outcomes. To evaluate the association of genetic polymorphisms with ASB, we defined 3 outcome groups: no ASB (<103 CFU/ml of uropathogen), medium ASB (>/=103 and <105 CFU/ml of uropathogen) and high ASB (>/=105 CFU/ml of uropathogen). We also evaluated ASB as an exposure with urine neutrophils or chemokines as the outcomes. For these analyses, only cultures with uropathogens were examined. Cultures with non-uropathogens (coagulase-negative staphylococci, other gram-negative rods, and mixed gram-positive flora) were not included in the definition of ASB. Furthermore, any culture with greater than or equal to 100,000 CFU/ml of coagulase-negative staphylococci, mixed gram-negative flora, or mixed gram-positive flora was excluded from the analysis to avoid samples that may have been contaminated with skin or perineal flora during collection (n = 139 excluded and n = 1122 analyzed further). Gram-negative uropathogens included E. coli non-hemolytic, E. coli beta-hemolytic, Proteus species, Enterobacter species, Klebsiella species, Citrobacter species, and Morganella morganii. Gram-positive uropathogens included Enterococcus species, Lactobacillus species, Group B Streptococcus, Staphylococcus aureus, and S. saprophyticus. In addition to stratifying by ASB level, we performed subgroup analyses of ASB caused by gram-negative and gram-positive pathogens.
###end p 24
###begin p 25
###xml 893 897 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Zhao1">[56]</xref>
For the genetic analyses, SNP genotypes (the exposure) and ASB status or (the outcomes) were examined with an allelic trend test. In the allelic trend test (also called a log-additive model) common homozygous genotypes (00) were assigned a value of 0, heterozygotes (01) a value of 1, and minor homozygous genotypes (11) a value of 2. Odds ratios and statistical significance values were then assessed using logistic regression models. We analyzed the ASB groups separately (medium ASB vs no ASB or high ASB vs no ASB) and as a combined group (medium + high ASB vs no ASB). Two-sided testing was used for all comparisons to evaluate statistical significance, considering a P-value of </=0.05 as significant. To verify that our significant findings were not due to population admixture, we also performed Caucasian subgroup analyses. All analyses were performed using the software Hplus or SAS [56]. Hardy-Weinberg equilibrium (HWE) testing was performed for all SNP genotypes using Haploview. All SNP genotypes satisfied Hardy-Weinberg in the Caucasian control group indicating that there were no genotyping errors or major effects of population heterogeneity.
###end p 25
###begin p 26
###xml 358 363 <span type="species:ncbi:9606">women</span>
###xml 417 422 <span type="species:ncbi:9606">women</span>
Univariate analyses were performed for categorical variables with a Chi-Square test; Fisher's exact test was used when the number of samples in a group was less than 5. The Mann-Whitney U-test was used to make comparisons of the chemokine levels between ASB Groups. We expressed the chemokine data as 75th or 90th percentile values due to the high number of women with undetectable urinary chemokines. The percent of women with undetectable chemokine levels was: 32.6% for CXCL-8, 39.1% for CXCL-5, 39.5% for CXCL-6, and 5.8% for sICAM-1. Chemokine levels were analyzed by genotype for each polymorphism with an allelic trend test using a general linear model.
###end p 26
###begin p 27
While these data were analyzed cross-sectionally, the study sample was originally selected for a study employing a case-control methodology, and thus case-control status could potentially confound the associations of current interest. To address this issue, we adjusted our analyses for case-control status, finding that this design variable did not act as a confounder. We also incorporated an interaction term for case-control status and the exposures of interest, to assess possible heterogeneity in associations.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Study Population Characteristics
###end title 29
###begin p 30
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 427 428 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 435 436 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 464 465 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 684 691 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t001">Table 1</xref>
###xml 980 987 970 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t001">Table 1</xref>
###xml 1021 1028 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1033 1045 1023 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus</italic>
###xml 1094 1101 1084 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t001">Table 1</xref>
###xml 294 299 <span type="species:ncbi:9606">women</span>
###xml 501 506 <span type="species:ncbi:9606">women</span>
###xml 810 815 <span type="species:ncbi:9606">women</span>
###xml 1021 1028 <span type="species:ncbi:562">E. coli</span>
We used a cross-sectional approach to examine whether candidate gene polymorphisms were associated with bacteriuria, urine chemokines, or urine neutrophils. We also examined whether bacteriuria was associated with chemokine or neutrophil levels. Midstream voided urines were obtained from 1261 women during their asymptomatic enrollment clinic visits and used to define the three groups: no ASB (<103 cfu/ml), medium ASB (>/=103 to <105 cfu/ml), or high ASB (>/=105 cfu/ml). The ethnic backgrounds of women in these 3 groups were similar with a predominance of a Caucasian background (Caucasian frequency 77.6% in no ASB group, 74.1% in medium ASB group, and 84.8% in high ASB group (Table 1) The history of co-morbid conditions and urinary tract procedures was similar except that diabetes was more common in women with ASB (P</=0.01 for those with medium ASB and P</=0.05 for those with high ASB) and bladder or kidney surgery was more common in those with high ASB (P</=0.01) (Table 1). The predominant organisms were E. coli and Enterococcus with smaller numbers of various other bacteria (Table 1).
###end p 30
###begin title 31
Demographic and microbiologic characteristics of ASB study groups.
###end title 31
###begin p 32
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 66 67 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 73 74 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 91 92 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Definitions: CFU/ml of uropathogen: No ASB <103; Medium ASB: >/=103 & <105; High ASB: >/=105.
###end p 32
###begin p 33
Numbers and percentages in ethnicity subcategories can be greater than total number due to selection of more than one category for an individual.
###end p 33
###begin p 34
###xml 12 13 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
P</=0.01 or d P</=0.05, when compared to group with no ASB.
###end p 34
###begin p 35
For microbiology, numbers without percentages listed. The number of samples without growth of a specific pathogen in the "No ASB" group is left blank since it is the remainder of the 1122 individuals who had culture data available, but did not meet Medium or High ASB criteria.
###end p 35
###begin p 36
Not included in uropathogen definition for this study.
###end p 36
###begin title 37
TLR2 and CXCR1 Polymorphisms Are Associated with ASB
###end title 37
###begin p 38
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt2">[37]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Arbour1">[57]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn3">[58]</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn4">[59]</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn5">[60]</xref>
###xml 865 869 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Johnson1">[61]</xref>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Khor1">[62]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Misch1">[63]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Misch2">[64]</xref>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Schroder1">[65]</xref>
###xml 895 899 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Wurfel1">[66]</xref>
###xml 252 260 <span type="species:ncbi:9606">children</span>
We first examined whether polymorphisms in candidate immune response genes were associated with ASB. We examined 5 polymorphisms in CXCR1, as previous studies have described an association of 2 polymorphisms with an increased risk of pyelonephritis in children [37]. We also examined 5 polymorphisms in CXCR2 since it is a receptor for CXCL-8. One polymorphism (CXCR2_T997C) had no variation and was not examined further. Finally, we examined 7 well-characterized TLR-pathway variants since previous studies suggest that these SNPs are associated with altered TLR gene function and susceptibility to different infections. The polymorphisms include TLR1_G1805T (amino acid (AA) change S602I), TLR2_G2258A (AA R753Q), TLR4_A896G (AA D299G), TLR4_C1196T (AA T399I), TLR5_C1174T (AA R392STOP), TIRAP_C539T (AA S180L), and TIRAP_C558T (AA A186A) [57], [58], [59], [60], [61], [62], [63], [64], [65], [66].
###end p 38
###begin p 39
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t002">Table 2</xref>
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s001">Table S1</xref>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t003">Table 3</xref>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s002">Table S2</xref>
Polymorphism TLR2_2258A, a hyporesponsive allele, was associated with high ASB in that such subjects were more likely to have the minor 2258A allele than those without ASB (Table 2, high vs no ASB, Odds Ratio (OR) 3.44 (95% CI: 1.65-7.17, P = 0.001)). To adjust for population heterogeneity, we analyzed data in the Caucasian subgroup and found a similar association of TLR2_G2258A with high ASB (Table S1, high vs no ASB, OR 3.17 (95% CI: 1.52-6.61, P = 0.002)). When we examined ASB caused by gram-negative uropathogens, the results were similar (Table 3, for high vs no ASB, OR 4.82 (95% CI: 2.06-11.27, P = 0.0003. Also Table S2). We next examined possible confounding factors that might account for this association, including case (rUTI or pyelonephritis) and control (no UTI history) status. A logistic regression model with case-control status as a covariate found a similar association of TLR2_G2258A with ASB caused by gram-negative uropathogens (P = 0.0004, data not shown). In addition, we did not find any interaction between SNP TLR2_G2258A with case-control status (P = 0.964 for interaction).
###end p 39
###begin title 40
CXCR1, CXCR2, and TLR polymorphisms and ASB.
###end title 40
###begin p 41
For coding region SNPs, the name includes nucleotide numbering based on mRNA with start codon at 1. For non-coding region SNPs, the name is from the IIPGA database () and designated with a 'z" prefix. rs numbers from the dbSNP database are included when available. A log-additive model was used for analysis. P values </=0.05 in bold.
###end p 41
###begin p 42
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
no ASB: <103 CFU/ml, medium ASB: >103 and <105 CFU/ml; high ASB: >105 CFU/ml.
###end p 42
###begin p 43
Polymorphism CXCR2_T997C had no variation and could not be analyzed further.
###end p 43
###begin title 44
CXCR1, CXCR2, and TLR polymorphisms and ASB caused by gram-negative uropathogens.
###end title 44
###begin p 45
For coding region SNPs, the name includes nucleotide numbering based on mRNA with start codon at 1. For non-coding region SNPs, the name is from the IIPGA database () and designated with a 'z" prefix. rs numbers from the dbSNP database are included when available. A log-additive model was used for analysis. P values </=0.05 in bold.
###end p 45
###begin p 46
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
no ASB: <103 CFU/ml, medium ASB: >103 and <105 CFU/ml; high ASB: >105 CFU/ml.
###end p 46
###begin p 47
Polymorphism CXCR2_T997C had no variation and could not be analyzed further.
###end p 47
###begin p 48
###xml 94 101 94 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t002">Table 2</xref>
###xml 178 186 178 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s001">Table S1</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 393 400 393 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t002">Table 2</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t004">Table 4</xref>
We also found an association of polymorphisms TLR1_G1805T with ASB in an unadjusted analysis (Table 2). However, in the Caucasian subgroup, the TLR1 association was not present (Table S1). We recently found that SNPs TLR5_C1174T and TLR4_A896G were associated with different UTI outcomes [49]. There was no association of these TLR pathway polymorphisms with ASB status from all uropathogens (Table 2). Two TLR4 SNPs were associated with ASB caused by gram-positive organisms (Table 4). The biologic significance of this was not clear since TLR4 recognizes LPS, which is not present on most gram-positive organisms.
###end p 48
###begin title 49
CXCR1, CXCR2, and TLR polymorphisms and ASB caused by gram-positive uropathogens.
###end title 49
###begin p 50
For coding region SNPs, the name includes nucleotide numbering based on mRNA with start codon at 1. For non-coding region SNPs, the name is from the IIPGA database () and designated with a 'z" prefix. rs numbers from the dbSNP database are included when available. A log-additive model was used for analysis. P values </=0.05 in bold.
###end p 50
###begin p 51
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
no ASB: <103 CFU/ml, medium ASB: >103 and <105 CFU/ml; high ASB: >105 CFU/ml.
###end p 51
###begin p 52
Polymorphisms CXCR2_T997C and TLR4_A896G (in the High ASB group) had no variation and could not be analyzed further.
###end p 52
###begin p 53
###xml 124 132 124 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t002">Tables 2</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s001">S1</xref>
###xml 239 246 239 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t004">Table 4</xref>
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s003">Table S3</xref>
###xml 920 927 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t003">Table 3</xref>
###xml 1307 1316 1307 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s004">Tables S4</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008300.s005">S5</xref>
We did not find any associations of CXCR1 or CXCR2 polymorphisms with ASB in the entire group or in the Caucasian subgroup (Tables 2 and S1). However, several CXCR1 polymorphisms were associated with ASB caused by gram-positive pathogens (Table 4, SNP T92G, for high ASB, OR 2.44 (95% CI: 1.16-5.12, P = 0.018; SNP C1003T, for high ASB, OR 2.28 (1.05-4.96), P = 0.038); and SNP ZA11069G for all ASB, OR 0.51 (0.28-0.94), P = 0.03)). Two of these associations remained statistically significant when analyzed in the Caucasian only subgroup (Table S3, SNP T92G, for high ASB, OR 2.34 (95% CI: 1.07-5.14, P = 0.035; and SNP ZA11069G for all ASB, OR 0.51 (0.28-0.96), P = 0.036)). One SNP showed a similar magnitude of effect that was not statistically significant (SNP C1003T, for high ASB, OR 2.10 (0.92-4.83), P = 0.080). There were several associations of CXCR1 polymorphisms with ASB caused by gram-negative pathogens (Table 3). However, the biologic significance of these latter associations was less clear since they were only present at medium, but not high, levels of ASB. We also examined whether CXCR1 or CXCR2 polymorphisms were associated with a history of recurrent cystitis (rUTI) or pyelonephritis We did not find any significant associations in the entire group or the Caucasian only subgroup (Tables S4 and S5).
###end p 53
###begin p 54
Together, these results provide evidence that polymorphism TLR2_G2258A is associated with ASB (all ASB as well as ASB caused by gram-negative uropathogens) and CXCR1 is associated with ASB caused by gram-positive uropathogens.
###end p 54
###begin title 55
ASB Is Associated with Urine CXCL-8, but Not Other Chemokines
###end title 55
###begin p 56
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t005">Table 5</xref>
###xml 390 392 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 175 180 <span type="species:ncbi:9606">women</span>
###xml 762 767 <span type="species:ncbi:9606">women</span>
To examine whether ASB is associated with chemokine levels, we measured urine levels of CXCL-8, CXCL-5, CXCL-6, and sICAM-1. We also examined IL-6, but only a small number of women had detectable IL-6 levels (9 of 561during initial testing), so no further measurement or analysis was performed. CXCL-8 was associated with increasing levels of ASB (Table 5, P<0.001 when comparing no ASB (90th percentile value 55.7 pg/ml) vs. medium ASB (102.6 pg/ml) vs. high ASB (249.3 pg/ml). This association was present for ASB caused by both gram-negative as well as gram-positive pathogens. We also examined CXCL-5, CXCL-6, and sICAM-1 and found no difference in these outcomes by womens' ASB status. sICAM-1, in contrast to the other chemokines, had high basal levels in women without ASB. Together, these results suggest a selective association of ASB with CXCL-8, but not CXCL-5, CXCL-6, or ICAM-1.
###end p 56
###begin title 57
ASB and urine chemokine levels.
###end title 57
###begin p 58
P value for comparison of 3 ASB clinical groups (no ASB vs medium vs high). P values or comparisons less than 0.05 are in bold.
###end p 58
###begin title 59
ASB, CXCL-6, and CXCL-8 Are Associated with Urine Neutrophil Levels
###end title 59
###begin p 60
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t006">Table 6</xref>
###xml 435 442 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t006">Table 6</xref>
###xml 546 548 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
We next examined whether ASB is associated with neutrophil levels. ASB was associated with urine neutrophil levels with statistically significant results when comparing positive vs. negative levels of urine neutrophils (Table 6, OR 1.66 (95% CI: 1.14-2.41), P = 0.008). We also examined whether chemokines were associated with different neutrophil levels. CXCL-6 and CXCL-8 were associated with increasing levels of urine neutrophils (Table 6, P = 0.0068 & P<0.0001, respectively). The magnitude of the effect was most striking for CXCL-8 with 90th percentile values ranging from 32.5 pg/ml for those without urine neutrophils to 1578.3 pg/ml for those with high levels. CXCL-5 and sICAM-1 were not associated with urinary neutrophil levels. Together, these results demonstrate that CXCL-6 and CXCL-8 levels, but not CXCL-5 or sICAM-1, are associated with urine neutrophil levels.
###end p 60
###begin title 61
Urine neutrophil association with ASB and chemokine levels.
###end title 61
###begin p 62
Comparing Urine PMNs in those with and without ASB with "negative" PMN group as reference.
###end p 62
###begin p 63
Positive = combination of +, ++, and +++ neutrophil counts.
###end p 63
###begin p 64
Comparing chemokine values at different urine neutrophil levels.
###end p 64
###begin title 65
CXCR1 Polymorphism Is Associated with Urine CXCL-8 Level
###end title 65
###begin p 66
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008300-t007">Table 7</xref>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 398 406 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008300-g001">Figure 1</xref>
###xml 538 546 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008300-g001">Figure 1</xref>
###xml 94 99 <span type="species:ncbi:9606">women</span>
###xml 185 190 <span type="species:ncbi:9606">women</span>
###xml 460 465 <span type="species:ncbi:9606">women</span>
Finally, we examined whether DNA polymorphisms were associated with urine chemokine levels in women with ASB. One CXCR1 polymorphism (G827C) was associated with CXCL-8 concentration in women with ASB from all uropathogens (Table 7, P = 0.004). Genotype GG was associated with lower CXCL-8 (110.6 pg/ml 90th percentile) in comparison to genotypes GC or CC (385.6 pg/ml & 513.4 pg/ml, respectively) (Figure 1). We also examined the association of CXCR1_G827C in women with gram-negative and gram-positive ASB and found similar differences (Figure 1). CXCR2_ZT13639C, had a borderline association with CXCL-8 levels (P = 0.05). No other associations were found. Together, these results suggest a selective association of candidate gene polymorphisms with chemokine levels, with the most robust association of a CXCR1 polymorphism with CXCL-8 concentrations in those with ASB.
###end p 66
###begin title 67
###xml 64 69 <span type="species:ncbi:9606">women</span>
Association of a CXCR1 polymorphism with urine CXCL-8 levels in women with ASB.
###end title 67
###begin p 68
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 23 28 <span type="species:ncbi:9606">women</span>
Urine CXCL-8 levels in women with ASB were stratified by CXCR1_G827C genotypes and analyzed by a log-additive model. The 90th percentile median values are plotted with sample size for each genotype indicated.
###end p 68
###begin title 69
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt119">a</xref>
###xml 60 65 <span type="species:ncbi:9606">women</span>
CXCR1, CXCR2, and TLR polymorphisms and chemokine levels in women with ASBa.
###end title 69
###begin p 70
###xml 0 5 <span type="species:ncbi:9606">Women</span>
Women with ASB defined as those with > = 1000 CFU/ml of a uropathogen. Chemokine levels were analyzed by genotype for each polymorphism with a log-additive model.
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 133 138 <span type="species:ncbi:9606">women</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:9606">women</span>
In this manuscript, we investigated the variation and genetic regulation of inflammation associated with asymptomatic bacteriuria in women in order to gain insight into the early stages of human UTI pathogenesis. Our main findings are that polymorphisms in TLR2 and CXCR1 are associated with ASB and that a CXCR1 polymorphism is associated with urine CXCL-8 levels in women with ASB. In addition, we found that chemokine levels are selectively associated with ASB (CXCL-8, but not CXCL-5, CXCL-6, or ICAM-1) and urinary neutrophil levels (CXCL-6 and CXCL-8, but not CXCL-5 or sICAM-1.
###end p 72
###begin p 73
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 688 695 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 728 748 724 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Borrelia burgdorferi</italic>
###xml 757 761 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Schroder1">[65]</xref>
###xml 887 891 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Schroder1">[65]</xref>
###xml 893 897 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ogus1">[67]</xref>
###xml 1001 1005 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Tabel1">[47]</xref>
###xml 1085 1089 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hawn1">[49]</xref>
###xml 728 748 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 919 927 <span type="species:ncbi:9606">children</span>
###xml 1182 1190 <span type="species:ncbi:9606">children</span>
###xml 1319 1324 <span type="species:ncbi:9606">human</span>
There are several steps in UTI pathogenesis that could be regulated by genetic variation of immune response genes. One of the early steps is the establishment of bacteriuria, which often occurs from ascent of bacteria from the colon, to the periurethral region to the bladder. We found an association of TLR2_G2258A with ASB. Interestingly, this SNP was not associated with a history of rUTI or pyelonephritis in the same cohort [49]. Polymorphism TLR2_2258A encodes an arginine to glutamine amino acid change in the TIR signaling domain, mediates impaired signalling in HEK293 cells transfected with TLR2 in an NF-kappaB assay, and is associated with decreased cytokine production after ex vivo stimulation of whole blood with Borrelia burgdorferi lysates [65]. This polymorphism has been associated with protection from Lyme disease as well as increased susceptibility to tuberculosis [65], [67]. A previous study in children found an association of TLR2_G2258A with ASB as well as symptomatic UTIs [47]. Our results confirm these findings with ASB, but not cystitis, susceptibility [49] (39). This apparent contrast in results may be attributable to different study populations (children vs adults from different ethnic backgrounds). Together, these findings suggest that TLR2 signaling may impact susceptibility to human UTIs at an early stage that regulates the establishment of bacteriuria.
###end p 73
###begin p 74
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Davidoff1">[20]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Jacobson1">[22]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Jantausch1">[23]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Kassir1">[24]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Otto1">[27]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Benson1">[19]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Hedges1">[21]</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Olszyna1">[26]</xref>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Otto2">[28]</xref>
###xml 1053 1058 <span type="species:ncbi:9606">women</span>
In addition, we found a selective association of urinary chemokine levels (CXCL-8, but not CXCL-5, CXCL-6, or ICAM-1) with ASB. Even though CXCL-8, CXCL-5, and CXCL-6 are ligands for CXCR1 and CXCR2, our data suggest differential regulation of these chemokines in response to bacteriuria. With at least 8 chemokines involved in neutrophil chemotaxis, it is often difficult to elucidate specific and/or non-redundant roles of individual chemokines. By focusing on ASB, we attempted to discover which chemokines are involved with neutrophil migration during early steps in UTI pathogenesis. With progression of disease to a symptomatic stage, a different pattern of elevated chemokines likely occurs. Previous studies of urine chemokine levels have mainly focused on IL-6 and CXCL-8 during episodes of symptomatic cystitis [20], [22], [23], [24], [27]. We did not confirm the findings of previous studies of ASB with urine IL-6 levels, but did confirm previous reports of elevated CXCL-8 [19], [21]. Although urine CXCL-5 has been found to be elevated in women with cystitis or urosepsis, it has not been examined in ASB [26], [28]. To our knowledge, CXCL-6, and sICAM-1 have not been measured in previous studies of either symptomatic UTIs or ASB. Further studies of additional chemokines during ASB and other stages of disease should further elucidate the association of specific chemokines with specific steps in UTI pathogenesis.
###end p 74
###begin p 75
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ko1">[25]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Sligh1">[31]</xref>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Ley1">[68]</xref>
We also found a selective association of chemokines (CXCL-6, and CXCL-8, but not CXCL-5 or sICAM-1) with urine neutrophil levels. Previous studies demonstrated that urine neutrophil counts are associated with elevated CXCL-8 levels [25]. Depletion of CXCL-8 from urine decreased the chemotactic activity by an average of 54.7%, suggesting that additional chemokines are involved. Our data suggest that CXCL-6 is an additional chemokine involved in chemotaxis of neutrophils to the urine in the presence of bacteriuria. Interestingly, sICAM-1 was not associated with elevated urine neutrophils. sICAM-1 may have a different role in UTI pathogenesis, as it is expressed by endothelial cells rather than bladder epithelium or neutrophils [31]. sICAM-1 binds to MAC1 (CD11b-CD18) on neutrophils and facilitates PMN slowing and subsequent migration from the blood vessel lumen to the interstitial tissue [68]. With a different cell source and bladder location, sICAM-1 likely mediates a different step in PMN migration in comparison to CXCL-5, CXCL-6, and CXCL-8.
###end p 75
###begin p 76
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Lundstedt2">[37]</xref>
###xml 217 222 <span type="species:ncbi:9606">women</span>
We also found an association of several CXCR1 SNPs (T92G, C1003T, and ZA11069G) with ASB caused by gram-positive uropathogens. Furthermore, we found an association of polymorphism G827C in CXCR1 with CXCL-8 levels in women with ASB. This polymorphism (also called variant 2 or 6334:L19592), which encodes a serine to threonine substitution at amino acid 276, has previously been associated with risks of pyelonephritis and vesicoureteral reflux in childhood [37]. The mechanism underlying this association is not clear. One possibility is that CXCR1 variants regulate recruitment of neutrophils to the bladder in response to CXCL-8 produced by epithelial cells or neutrophils. If reduced numbers of neutrophils migrate to the bladder, then one source of CXCL-8 production will be eliminated. Further studies of the effects of CXCR-1_G827C on cyhemokine expression will be needed to clarify this mechanism.
###end p 76
###begin p 77
###xml 765 773 765 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 1583 1587 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008300-Czaja1">[69]</xref>
###xml 1486 1491 <span type="species:ncbi:9606">women</span>
Potential limitations of our study include effects of population admixture and multiple comparisons. To account for possible confounding effects from population heterogeneity, we performed our genetic analyses in the Caucasian subgroup as well as the entire cohort. Despite these attempts to minimize population admixture effects, we cannot exclude this possibility. A second possible limitation is the issue of multiple comparisons. As a matter of hypothesis testing, we prioritized seven well-characterized TLR pathway functional polymorphisms and 10 SNPs in the two major receptors involved in neutrophil chemotaxis. SNPs with well-characterized function do not generally have the same requirement for adjustments for multiple comparisons, due to a well-founded a priori hypothesis of their potential association with a cellular function. Even if a strict Bonferroni correction were taken for the association of TLR2_G2258A with ASB, the adjusted P value would remain significant at <0.017 (17 polymorphisms x <0.001 for high vs no ASB comparison). Regardless of which adjustments are chosen for our data, convincing evidence of a genetic effect ultimately requires replication studies as well as detailed analysis of functional effects of each polymorphism. Another limitation is that our cross-sectional study design does not enable us to assess whether the ASB episodes in our population are linked to a future occurrence of cystitis. We recently completed a prospective study of women with recurrent cystitis that included daily urine sampling prior to an episode of cystitis [69]. With such a study design, it may be feasible to analyze whether genetic variation and urine inflammatory profiles associated with ASB are predictive of a subsequent cystitis episode.
###end p 77
###begin p 78
Our study also has numerous strengths. First, to our knowledge this is the largest study to examine associations of gene polymorphisms and susceptibility to ASB, and is the only study to date to examine this phenotype in adults. Second, we used a population-based sampling strategy which increases the likelihood that our findings are representative of the population. Finally, this is the first study to examine the association of polymorphisms with urine chemokine and neutrophil levels.
###end p 78
###begin p 79
In summary, our results suggest that genetic variation of TLR and chemokine pathways is associated with asymptomatic bacteriuria and urine chemokine levels. Examining genetic regulation of the urinary tract immune response during ASB provides an opportunity to understand early events in pathogenesis prior to the complex cytokine and chemokine inflammatory cascades present during symptomatic cystitis episodes.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
CXCR1, CXCR2, & TLR polymorphisms & ASB (Caucasian only).
###end p 81
###begin p 82
(0.22 MB RTF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
CXCR1, CXCR2, & TLR polymorphisms & ASB secondary to gram-negative uropathogens for Caucasian only.
###end p 84
###begin p 85
(0.18 MB RTF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
CXCR1, CXCR2, & TLR polymorphisms & ASB secondary to gram-positive uropathogens for Caucasian only.
###end p 87
###begin p 88
(0.17 MB RTF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
CXCR1 and CXCR2 polymorphisms & clinical history of rUTI or pyelonephritis.
###end p 90
###begin p 91
(0.11 MB RTF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
CXCR1 and CXCR2 polymorphisms & clinical history of rUTI or pyelonephritis for Caucasians only.
###end p 93
###begin p 94
(0.12 MB RTF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
We thank Patricia Yarbro, Jane Grafton, Kelli O'Hara, Linda Wehnes, Holly Roberts, and Robin Gosney at Group Health for project management, programming, recruitment, and data collection and tracking. We also thank Carey Cassidy, Marsha Cox, Sarah Li, Sheila Manuguid, Rick Wells, and Yuliya Yarova-Yarovaya for technical assistance and Richard Laws for database assistance.
###end p 96
###begin title 97
References
###end title 97
###begin article-title 98
Bacteriuria of pregnancy-a critical appraisal.
###end article-title 98
###begin article-title 99
The natural history of recurrent bacteriuria in schoolgirls.
###end article-title 99
###begin article-title 100
Aprospective study of urinary-tract infections in a Dutch general practice.
###end article-title 100
###begin article-title 101
###xml 73 78 <span type="species:ncbi:9606">women</span>
A prospective study of asymptomatic bacteriuria in sexually active young women.
###end article-title 101
###begin article-title 102
###xml 82 87 <span type="species:ncbi:9606">women</span>
The frequency and character of urinary tract infections in an unselected group of women.
###end article-title 102
###begin article-title 103
Asymptomatic infections of the urinary tract.
###end article-title 103
###begin article-title 104
###xml 38 43 <span type="species:ncbi:9606">women</span>
###xml 125 130 <span type="species:ncbi:9606">women</span>
Bacteriuria in a population sample of women: 24-year follow-up study. Results from the prospective population-based study of women in Gothenburg, Sweden.
###end article-title 104
###begin article-title 105
Asymptomatic bacteriuria in the elderly.
###end article-title 105
###begin article-title 106
Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria. A case-control study.
###end article-title 106
###begin article-title 107
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases.
###end article-title 107
###begin article-title 108
###xml 14 30 <span type="species:ncbi:562">Escherichia coli</span>
Uropathogenic Escherichia coli as a model of host-parasite interaction.
###end article-title 108
###begin article-title 109
Pathogen recognition and innate immunity.
###end article-title 109
###begin article-title 110
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.
###end article-title 110
###begin article-title 111
Recognition of microorganisms and activation of the immune response.
###end article-title 111
###begin article-title 112
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 51 67 <span type="species:ncbi:562">Escherichia coli</span>
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection.
###end article-title 112
###begin article-title 113
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection.
###end article-title 113
###begin article-title 114
A toll-like receptor that prevents infection by uropathogenic bacteria.
###end article-title 114
###begin article-title 115
Chemokines and their receptors: drug targets in immunity and inflammation.
###end article-title 115
###begin article-title 116
###xml 31 39 <span type="species:ncbi:9606">children</span>
Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria.
###end article-title 116
###begin article-title 117
Multiple urinary cytokine levels of bacterial cystitis.
###end article-title 117
###begin article-title 118
###xml 65 70 <span type="species:ncbi:9606">women</span>
Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria.
###end article-title 118
###begin article-title 119
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function.
###end article-title 119
###begin article-title 120
###xml 43 51 <span type="species:ncbi:9606">children</span>
Urinary interleukin-6 and interleukin-8 in children with urinary tract infection.
###end article-title 120
###begin article-title 121
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.
###end article-title 121
###begin article-title 122
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Elevated interleukin-8 levels in the urine of patients with urinary tract infections.
###end article-title 122
###begin article-title 123
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis.
###end article-title 123
###begin article-title 124
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection.
###end article-title 124
###begin article-title 125
Chemokine response to febrile urinary tract infection.
###end article-title 125
###begin article-title 126
###xml 109 114 <span type="species:ncbi:9606">human</span>
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.
###end article-title 126
###begin article-title 127
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Cxc chemokine receptor 2 contributes to host defense in murine urinary tract infection.
###end article-title 127
###begin article-title 128
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1.
###end article-title 128
###begin article-title 129
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human model: a genetic dissection of immunity to infection in natural conditions.
###end article-title 129
###begin article-title 130
###xml 30 35 <span type="species:ncbi:9606">human</span>
Genetics of susceptibility to human infectious disease.
###end article-title 130
###begin article-title 131
Genetic and environmental influences on premature death in adult adoptees.
###end article-title 131
###begin article-title 132
###xml 81 86 <span type="species:ncbi:9606">women</span>
Evaluation of a familial predisposition to recurrent urinary tract infections in women.
###end article-title 132
###begin article-title 133
Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.
###end article-title 133
###begin article-title 134
A genetic basis of susceptibility to acute pyelonephritis.
###end article-title 134
###begin article-title 135
###xml 60 65 <span type="species:ncbi:9606">women</span>
Risk factors for recurrent urinary tract infection in young women.
###end article-title 135
###begin article-title 136
###xml 61 66 <span type="species:ncbi:9606">women</span>
Risk factors associated with acute pyelonephritis in healthy women.
###end article-title 136
###begin article-title 137
Effects of recent sexual activity and use of a diaphragm on the vaginal microflora.
###end article-title 137
###begin article-title 138
###xml 92 97 <span type="species:ncbi:9606">women</span>
ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women.
###end article-title 138
###begin article-title 139
###xml 90 95 <span type="species:ncbi:9606">women</span>
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.
###end article-title 139
###begin article-title 140
Non-secretor status is associated with female acute uncomplicated pyelonephritis.
###end article-title 140
###begin article-title 141
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.
###end article-title 141
###begin article-title 142
###xml 67 75 <span type="species:ncbi:9606">children</span>
P blood group and proneness to urinary tract infection in Japanese children.
###end article-title 142
###begin article-title 143
Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis.
###end article-title 143
###begin article-title 144
###xml 80 88 <span type="species:ncbi:9606">children</span>
Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children.
###end article-title 144
###begin article-title 145
###xml 154 162 <span type="species:ncbi:9606">children</span>
Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children.
###end article-title 145
###begin article-title 146
###xml 89 94 <span type="species:ncbi:9606">women</span>
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women.
###end article-title 146
###begin article-title 147
###xml 43 51 <span type="species:ncbi:9606">children</span>
Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.
###end article-title 147
###begin article-title 148
###xml 73 78 <span type="species:ncbi:9606">women</span>
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.
###end article-title 148
###begin article-title 149
Manual of clinical microbiology.
###end article-title 149
###begin article-title 150
Multilocus LD measure and tagging SNP selection with generalized mutual information.
###end article-title 150
###begin article-title 151
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease.
###end article-title 151
###begin article-title 152
MALDI-TOF mass spectrometry-based SNP genotyping.
###end article-title 152
###begin article-title 153
A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.
###end article-title 153
###begin article-title 154
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
###end article-title 154
###begin article-title 155
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' Disease.
###end article-title 155
###begin article-title 156
A polymorphism in toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis.
###end article-title 156
###begin article-title 157
###xml 9 14 <span type="species:ncbi:9606">human</span>
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
###end article-title 157
###begin article-title 158
Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy.
###end article-title 158
###begin article-title 159
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
###end article-title 159
###begin article-title 160
###xml 55 60 <span type="species:ncbi:9606">human</span>
Toll-like receptor polymorphisms and susceptibility to human disease.
###end article-title 160
###begin article-title 161
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction.
###end article-title 161
###begin article-title 162
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 80 100 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.
###end article-title 162
###begin article-title 163
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.
###end article-title 163
###begin article-title 164
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease.
###end article-title 164
###begin article-title 165
Getting to the site of inflammation: the leukocyte adhesion cascade updated.
###end article-title 165
###begin article-title 166
###xml 82 87 <span type="species:ncbi:9606">women</span>
Prospective cohort study of microbial and inflammatory urinary tract infection in women.
###end article-title 166
###begin p 167
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 167
###begin p 168
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant #2 PO1 DK53369-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 168

